Log in to your Inderes Free account to see all free content on this page.
XP Chemistries
0.18 SEK
-0.27 %
Less than 1K followers
XPC
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for XP Chemistries
P/B
Median 2021-2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share price (SEK) | 2.44 | 0.43 | 0.12 | 0.10 | 0.18 |
| Shares | 29.7 | 37.3 | 96.0 | 204.3 | 314.0 |
| Market cap | 72.4 | 16.1 | 11.1 | 19.9 | 56.4 |
| Enterprise value | 51.0 | - | - | - | - |
| EV/S | 182.8 | - | - | - | - |
| EV/EBITDA | neg. | - | - | - | - |
| EV/EBIT | neg. | - | - | - | - |
| P/E | neg. | neg. | neg. | neg. | neg. |
| P/B | 2.31 | 0.55 | 0.43 | 0.92 | 1.53 |
| P/S | 259.5 | 15.2 | 16.8 | 71.0 | 172.1 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 91.0 % | 94.8 % | 94.4 % | 94.9 % | 97.0 % |
| Gearing ratio | - | - | - | - | - |
Login required
This content is only available for logged in users